Found: 8
Select item for more details and to access through your institution.
Awardee Summary of 2023 Taiwan Oncology Society Clinical Research Award Recipient: Persistent Endeavors on Research of Digestive Cancers for Three Decades.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 1, p. 1, doi. 10.4103/ejcrp.ejcrp-d-23-00044
- By:
- Publication type:
- Article
Interpreting Cancer Incidence Rates and Trends: A Review of Control Factors and Worldwide Statistics.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 1, p. 7, doi. 10.4103/ejcrp.eJCRP-D-23-00046
- By:
- Publication type:
- Article
Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 1, p. 18, doi. 10.4103/ejcrp.eJCRP-D-23-00050
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor Exon 19 Deletion Subtypes Do Not Influence Survival Outcomes Following First-line Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Advanced Nonsmall Cell Lung Cancer Patients.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 1, p. 28, doi. 10.4103/ejcrp.eJCRP-D-23-00043
- By:
- Publication type:
- Article
Life-threatening Pneumocystis jiroveci Pneumonia with Cytomegalovirus Coinfection in a Follicular Lymphoma Patient During Rituximab-based Chemotherapy.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 1, p. 39, doi. 10.4103/ejcrp.eJCRP-D-23-00015
- By:
- Publication type:
- Article
An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature Review.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 1, p. 44, doi. 10.4103/ejcrp.eJCRP-D-23-00032
- By:
- Publication type:
- Article
Promising Remission with Reduced Bevacizumab and Pembrolizumab Dosage in a Patient with AT-rich Interaction Domain 1A Mutated Ovarian Clear-cell Carcinoma Refractory to Chemotherapy.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 1, p. 49, doi. 10.4103/ejcrp.eJCRP-D-23-00035
- By:
- Publication type:
- Article
David Slays Goliath: Exceptional Efficacy of Oral Vinorelbine in Conquering Metastatic Finger Angiosarcoma.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 1, p. 53, doi. 10.4103/ejcrp.eJCRP-D-23-00033
- By:
- Publication type:
- Article